RLMD Relmada Therapeutics Forecast, Technical & Fundamental Analysis

a clinical-stage biotechnology company, which engages in the development of d-methadone receptor antagonist, which is a chemical entity that addresses areas of high unmet medical need in the treatment of central nervous system diseases

Industry Biotechnology

Get AI intraday signals

RLMD

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For RLMD
(Try 14 days for $1 only)

View a ticker or compare two or three

Compare

RLMD

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For RLMD
(Try 14 days for $1 only)

Ad is loading...

A.I. Advisor

published Earnings

RLMD is expected to report earnings to rise 32.63% to -78 cents per share on November 07

Relmada Therapeutics RLMD Stock Earnings Reports

Q3'24

Est.

$-0.78

Q2'24

Beat

by $0.24

Q1'24

Beat

by $0.26

Q4'23

Missed

by $0.01

Q3'23

Beat

by $0.18

The last earnings report on August 07 showed earnings per share of -58 cents, beating the estimate of -82 cents. With 168.69K shares outstanding, the current market capitalization sits at 101.69M.

A.I. Advisor

published General Information

General Information

a clinical-stage biotechnology company, which engages in the development of d-methadone receptor antagonist, which is a chemical entity that addresses areas of high unmet medical need in the treatment of central nervous system diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

2222 Ponce de Leon Boulevard

Phone

+1 786 629-1376

Employees

Web

https://www.relmada.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
GME	23.14	-0.28	-1.20%
GameStop Corp
TSLA	210.60	-3.51	-1.64%
Tesla
SPY	552.08	-11.60	-2.06%
SPDR® S&P 500® ETF Trust
AAPL	222.77	-6.23	-2.72%
Apple
BTC.X	57431.023000	-1681.457000	-2.84%
Bitcoin cryptocurrency

RLMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RLMD has been loosely correlated with ENTO. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if RLMD jumps, then ENTO could also see price increases.

Ticker / NAME	Correlation To RLMD	1D Price Change %
RLMD	100%	-2.14%
ENTO - RLMD	37% Loosely correlated	+2.41%
CYTK - RLMD	30% Poorly correlated	-4.41%
CABA - RLMD	27% Poorly correlated	-10.12%
ATXS - RLMD	27% Poorly correlated	-6.30%
ONCT - RLMD	26% Poorly correlated	-0.51%
More